Mylonib 15mg tablet

Mylonib 15mg is an oral oncological medicine that contains the active substance Ruxolitinib (phosphate) and is called JAK inhibitor. This treatment affects the signaling of certain cells, leading to the reduction of the spleen size and the decrease of the inflammatory cytokines in the case of myeloproliferative diseases.
Primary UsesMylonib 15mg is prescribed for the treatment of:Myelofibrosis – severe disease of the bone marrow, which leads to disruption of the production of blood cells.Polycythemia Vera – a blood cancer that involves excessive production of red blood cells by the bone marrow.Graft-Versus-Host Disease (GVHD) – the condition used to treat immune damage of tissues after stem cell transplantation.